Level Biotechnology Inc. (TPEX: 3118)
Health Care · Health Care Providers & Services · TW
NT$31.50
-0.94% today · -3.1% 1Y
Level Biotechnology Inc. (TPEX: 3118) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $32.10M and employs 128 people.
Over the last twelve months the share price has lost 3.1%, trading between 30.85 and 34.70.
Tweenvest scores Level Biotechnology Inc. across four factors: quality 84/100, value 37/100, growth 43/100, dividend 59/100. Its strongest factor is quality.
3118 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $32.10M
- Revenue (TTM)
- $22.30M
- P/E
- 13.51
- EPS
- 2.33
- Dividend yield
- 6.98%
- Beta (5Y)
- 0.23
- 52-week high
- NT$34.70
- 52-week low
- NT$30.85
- Avg volume (3M)
- —
- Shares outstanding
- 32.45M
- Employees
- 128
- Next earnings
- —
About Level Biotechnology Inc.
Level Biotechnology Inc., founded in 1989 and based in New Taipei City, Taiwan, operates in the commercialization and distribution of scientific products and services. The company supplies specialized reagents and consumables for cell culture, immunology, and molecular biology, alongside advanced biomedical instrumentation, throughout Taiwan. Beyond product distribution, Level Biotechnology offers a comprehensive suite of research and testing services. These include expert assessments in mammalian and genetic toxicology, pharmacological studies, biocompatibility testing, and the production of model animals. The firm's preclinical research capabilities serve a diverse range of clients in the biotechnology, pharmaceutical, medical device, animal health, and agrichemical industries.
- ISIN
- TW0003118006
- Founded
- 1989
- Listed since
- Aug 20, 2008
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $355.98B | $396.59 | -0.54% |
| CVS Health CorporationNYSE: CVS | $118.82B | $92.90 | -1.29% |
| McKesson CorporationNYSE: MCK | $105.52B | $905.09 | +3.58% |
| HCA Healthcare, Inc.NYSE: HCA | $92.83B | $428.76 | -0.11% |
| Elevance Health, Inc.NYSE: ELV | $86.50B | $398.87 | -0.93% |
| The Cigna GroupNYSE: CI | $73.81B | $279.32 | -0.40% |
| Cencora, Inc.NYSE: COR | $62.60B | $328.06 | +1.33% |
| Cardinal Health, Inc.NYSE: CAH | $55.33B | $237.92 | +2.39% |
Figures last refreshed Aug 18, 2026.